AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 29 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $5,166,000 | -22.7% | 4,724,000 | 0.0% | 0.20% | -21.1% |
Q4 2016 | $6,686,000 | +25.1% | 4,724,000 | -0.0% | 0.25% | +32.1% |
Q3 2016 | $5,346,000 | +1.0% | 4,726,000 | -1.0% | 0.19% | -1.0% |
Q2 2016 | $5,293,000 | +2.2% | 4,774,000 | 0.0% | 0.19% | +13.6% |
Q1 2016 | $5,179,000 | -13.1% | 4,774,000 | +1.1% | 0.17% | -12.9% |
Q4 2015 | $5,958,000 | +146.9% | 4,724,000 | +214.9% | 0.19% | +173.2% |
Q3 2015 | $2,413,000 | -37.8% | 1,500,000 | 0.0% | 0.07% | -28.3% |
Q2 2015 | $3,879,000 | -62.7% | 1,500,000 | -70.0% | 0.10% | -62.1% |
Q1 2015 | $10,392,000 | +24.3% | 5,000,000 | 0.0% | 0.26% | +29.2% |
Q4 2014 | $8,362,000 | +25.0% | 5,000,000 | 0.0% | 0.20% | +19.5% |
Q3 2014 | $6,688,000 | +26.0% | 5,000,000 | 0.0% | 0.17% | +31.0% |
Q2 2014 | $5,309,000 | +4.1% | 5,000,000 | 0.0% | 0.13% | +3.2% |
Q1 2014 | $5,100,000 | – | 5,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |